A Safety Study of SEA-BCMA in Patients With Multiple Myeloma

NCT03582033 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

83

Enrollment

INDUSTRY

Sponsor class

Stopped Study closed due to portfolio prioritization

Conditions

Multiple Myeloma

Interventions

DRUG: SEA-BCMA
DRUG: dexamethasone
DRUG: pomalidomide

Sponsor

Seagen Inc.